anika_new_logo_highres_360x133 (002) (1).png
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024 16:45 ET | Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September...
anika_new_logo_highres_360x133 (002) (1).png
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 15, 2024 16:01 ET | Anika Therapeutics Inc.
BEDFORD, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1,...
anika_new_logo_highres_360x133 (002) (1).png
Anika Reports Second Quarter 2024 Financial Results
August 08, 2024 16:05 ET | Anika Therapeutics Inc.
Expanded Regenerative Solutions portfolio with full market release of the Integrity™ Implant System, a hyaluronic acid (HA)-based scaffold for rotator cuff and other tendon repairs, generating...
anika_new_logo_highres_360x133 (002) (1).png
Anika to Participate in the Sidoti Virtual Investor Conference
August 05, 2024 16:01 ET | Anika Therapeutics Inc.
BEDFORD, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
anika_new_logo_highres_360x133 (002) (1).png
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 25, 2024 09:00 ET | Anika Therapeutics Inc.
BEDFORD, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
anika_new_logo_highres_360x133 (002) (1).png
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024 07:19 ET | Anika Therapeutics Inc.
BEDFORD, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on July 1,...
anika_new_logo_highres_360x133 (002) (1).png
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
July 11, 2024 08:30 ET | Anika Therapeutics Inc.
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries...
anika_new_logo_highres_360x133 (002) (1).png
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024 16:01 ET | Anika Therapeutics Inc.
BEDFORD, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3,...
anika_new_logo_highres_360x133 (002) (1).png
Anika Enters into Cooperation Agreement with Caligan Partners
May 28, 2024 16:05 ET | Anika Therapeutics Inc.
Appoints Joseph Capper and William Jellison to Board of DirectorsAnnounces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc....
anika_new_logo_highres_360x133 (002) (1).png
Anika Announces CFO Transition
May 08, 2024 16:08 ET | Anika Therapeutics Inc.
BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it has appointed...